PremiumThe FlyBluebird Bio, SK Capital Partners amend merger agreement Carlyle, SK receive approvals to complete Bluebird Bio acquisition Bluebird reports Ayrmid did not submit binding proposal to acquire the company PremiumThe FlyBiotech Alert: Searches spiking for these stocks today Bluebird Bio price target lowered to $5 from $40 at Wells Fargo Bluebird Bio upgraded to Neutral from Underweight at JPMorgan PremiumThe FlyBluebird Bio trading halted, volatility trading pause Bluebird Bio downgraded to Neutral from Outperform at Baird Morning Movers: Bluebird Bio shares tumble following take-private deal